Abstract
There is no accurate clinicopathological risk model for localized advanced esophageal squamous cell carcinoma (LA-ESCC) that can be used to guide treatment by predicting prognosis. This study aimed to investigate the use of the novel biomarker peripheral absolute monocyte count (AMC) as independent prognostic factor for LA-ESCC with esophagectomy.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call